Home  >  Products  >  PAXIP1 (PAX interacting (with transcription-activation domain) protein 1) Blocking Peptide (100ug)
PAXIP1 (PAX interacting (with transcription-activation domain) protein 1) Blocking Peptide (100ug)

PAXIP1 (PAX interacting (with transcription-activation domain) protein 1) Blocking Peptide (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-PAXIP1 antibody (Catalogue #: ARP51642_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP51642
Size: 100 ug
Weight: 74kDa
Gene: 22976
Format: Lyophilized powder
Target: PAXIP1 functions as a key component of the DNA damage response, and phosphoserine or phosphothreonine-specific binding modules. PAXIP1 recognizes substrates phosphorylated by the kinases ataxia telangiectasia-mutated (ATM), ataxia telangiectasia and RAD3-related (ATR) in response to gamma irradiation. It may play a role in PAX2-dependent transcriptional regulation. PAXIP1 plays a role in early development, most probably in cell proliferation.
Alternative names: PTIP; TNRC2; CAGF28; CAGF29; PACIP1; PAXIP1L; FLJ41049
See Full Product Listings >